Clinical Trial Update: Tamoxifen in Treating Women With High-Risk Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on using tamoxifen to treat women at high risk for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED